VYNE — Vyne Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Vyne Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2019 December 31st	C2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-Q	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	55.9	57.6	42.3	30.9	30.6
Net Total Accounts Receivable
Net Total Receivables	0.135	15.8	7.58	5.17	0
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	76.4	87.3	63.2	38.3	96
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.58	2.14	0.354	0	0.207
Net Goodwill
Other Long Term Assets
Total Assets	81.2	93.7	67	40.8	97.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	29.3	21.8	18.4	9.35	7.54
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	63.6	56.2	18.4	9.35	8.95
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	17.6	37.5	48.6	31.4	88.7
Total Liabilities & Shareholders' Equity	81.2	93.7	67	40.8	97.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding